N
Newland Pharmaceutical Co Ltd
SZSE:301277
Newland Pharmaceutical Co Ltd
SZSE:301277
Price:
11.46
CNY
0.79%
Market Closed
Market Cap:
¥4.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Newland Pharmaceutical Co Ltd
SZSE:301277
|
CN |
|
C
|
Chengbang Eco-Environment Co Ltd
SSE:603316
|
CN |
|
S
|
Silver Bullet Data Services Group PLC
LSE:SBDS
|
UK |
Multiples-Based Value
The Multiples-Based Value of one Newland Pharmaceutical Co Ltd stock under the Base Case scenario is 7.37 CNY. Compared to the current market price of 11.46 CNY, Newland Pharmaceutical Co Ltd is Overvalued by 36%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
7.37
CNY
Overvaluation 36%
N
Multiples Across Competitors
Competitors Multiples
Newland Pharmaceutical Co Ltd Competitors
Newland Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
N
|
Newland Pharmaceutical Co Ltd
SZSE:301277
|
4.5B CNY | 6.7 | 36.3 | 29.7 | 29.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.9 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
